Acadia Pharmaceuticals

ACAD

34.33

+0.50

+1.5%

After Hours:

33.83

-0.50

-1.5%

Stock Price
Open: 33.87
Prev. Close: 33.83
Low/Hi: 33.50 - 34.39
52-Week: 20.68 - 42.49
Volumes
Equity: 1,073,424
90-Day Avg: 2,130,908
Option: 857
90-Day Avg: 3,805
Volatility
Today: 22.2
20-Day: 38.5
52-Week: 55.8
30-Day IV: 54.1 +0.6
IV Rank: 0.31 (Subdued)
Fundamental
Div. Yield: 0.0%
Earnings: 5-May (Est.)
P/E Ratio:
Market Cap: 4.1 B
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACAD Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 163,620 153,679 131,774 175,220
Short Term Investments 365,416 435,180 280,781 282,023
Investments - - - -
Accounts Receivable 7,140 5,224 1,633 783
Inventory 4,175 4,301 2,867 0
Loans - - - -
Prepaid Expenses 7,546 5,106 6,842 4,326
Net Property Plant and Equipment 3,081 3,159 2,897 2,623
Other Current Assets 0 0 0 0
Current Assets 547,897 603,490 423,897 462,352
Goodwill and Intangibles 7,015 7,385 7,754 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 561,153 617,384 438,034 466,590
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,160 3,350 3,486 1,615
Accounts Payable 3,912 2,828 1,024 1,307
Accrued Liabilities and Other Payables 36,029 34,445 27,485 19,815
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 42,742 39,326 29,219 21,339
Other Current Liabilities 2,644 1,876 513 0
Accumulated Other Comprehensive Income 106 533 206 316
Preferred Stock 0 0 0 0
Current Liabilities 42,585 39,149 29,022 21,122
Common Stock 12 12 11 11
Other Non-Current Liabilities 157 177 197 217
Additional Paid-In Capital 1,452,272 1,432,796 1,192,268 1,157,272
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -933,979 -855,283 -783,670 -712,348
Total Equity 518,411 578,058 408,815 445,251
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 163,620 102,138 61,854 11,707
Short Term Investments 365,416 112,994 260,632 174,083
Investments - - - -
Accounts Receivable 7,140 1,638 964 0
Inventory 4,175 0 0 0
Loans - - - -
Prepaid Expenses 7,546 2,219 1,168 2,570
Net Property Plant and Equipment 3,081 2,203 553 579
Other Current Assets 0 0 0 0
Current Assets 547,897 218,989 324,618 188,360
Goodwill and Intangibles 7,015 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 561,153 221,896 325,458 189,118
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,160 704 287 179
Accounts Payable 3,912 1,672 2,016 372
Accrued Liabilities and Other Payables 36,029 20,230 13,818 6,552
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 42,742 22,134 15,969 6,987
Other Current Liabilities 2,644 0 0 55
Accumulated Other Comprehensive Income 106 11 -9 48
Preferred Stock 0 0 0 0
Current Liabilities 42,585 21,902 15,834 6,979
Common Stock 12 10 10 9
Other Non-Current Liabilities 157 232 135 8
Additional Paid-In Capital 1,452,272 862,327 807,631 587,742
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -933,979 -662,586 -498,143 -405,668
Total Equity 518,411 199,762 309,489 182,131